You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

25 August 2020

Half of people living with HIV who need a repeat viral load test received it late

National study finds high levels of repeat viral load monitoring among people whose HIV treatment is beginning to fail – but test waiting times are too long.

20 August 2020

Burundian women with disabilities three times more likely to be living with HIV

Research suggests women with disabilities are significantly more vulnerable to HIV than other women and disabled men – and that this is linked to sexual violence.

12 August 2020

Peer-based clubs may offer valuable PrEP initiation support to adolescent girls and young women

An evaluation of peer support clubs in settings with high HIV and gender-based violence prevalence finds increased self-esteem and self-efficacy among participants.

05 August 2020

The potential of social media to better engage gay and bisexual men in HIV prevention

Reuben Silungwe explains how social media and related online platforms are impacting the HIV response in Zambia.

31 July 2020

‘Significant step’ for HIV prevention as vaginal ring gets green light from the European Medicines Agency

Ring containing the antiretroviral drug dapivirine could be available in Africa as early as 2021 after it was found to reduce women’s HIV risk by 30 to 50%.

29 July 2020

What happens when stigma and discrimination take the place of compassion

Levy Ngosa explores how the knock-on effect of discriminatory laws and policies impede access to HIV prevention and treatment services

27 July 2020

Asian study links low-level viraemia with treatment failure in children living with HIV

Children living with HIV who experience episodes where they have detectable but low-levels of virus in their blood, while on treatment, are at increased risk of viral failure.

23 July 2020

Injectable PrEP – an exciting tool, but no silver bullet for adherence

We talk to Giffin Daughtridge, CEO of medical diagnostics company, UrSure, about treatment adherence and the impact of long-acting cabotegravir as injectable PrEP.

22 July 2020

Sexual health and rights for sex workers - via SMS

An SMS service co-created with sex workers to improve their sexual health met with keen approval during testing.

15 July 2020

High levels of HIV, low levels of treatment in gay men and trans woman in Johannesburg

Around 40% of transgender women and gay men tested HIV positive in Johannesburg – but only a third are on treatment.